Prevalence of Class 1 Integron and In Vitro Effect of Antibiotic Combinations of Multidrug-Resistant Enterococcus Species Recovered from the Aquatic Environment in the Eastern Cape Province, South Africa.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Enterococcus faecium*/genetics ; Gram-Positive Bacterial Infections*/microbiology; Humans ; Enterococcus ; Integrons/genetics ; Vancomycin/pharmacology ; South Africa ; Prevalence ; Anti-Bacterial Agents/pharmacology ; Enterococcus faecalis ; Ciprofloxacin/pharmacology ; Gentamicins/pharmacology ; Microbial Sensitivity Tests

Enterococci are regarded as a better indication of faecal pollution in freshwater and marine waters. Their levels in seawater are positively connected with swimming-related gastrointestinal disorders. This study used an Enterococcus -specific polymerase chain reaction (PCR) to characterize the isolates. Classes 1 and 2 integrons were examined for environmental Enterococcus isolates using a standard biological procedure. All strains were assessed against a panel of 12 antibiotics from various classes using disc diffusion methods. The microdilution method was used to work out the minimum inhibitory concentration (MIC) according to the CLSI guiding principles. The combination therapy of the resistant drugs was evaluated using a checkerboard assay and a time-dependent test for assessing their bactericidal or bacteriostatic activity. The gene diversity of the tested organisms was analyzed with the aid of Enterobacterial Repetitive Intergenic Consensus (ERIC) PCR. In total, 57 Enterococcus spp. environmental samples were recovered, in which Enterococcus faecalis (33.33%) and Enterococcus faecium (59.65%) were the dominant species. Resistance to linezolid, ciprofloxacin, erythromycin, gentamicin, vancomycin, rifampicin, and tetracycline was prevalent. Fifty (50) strains tested positive for class 1 integron, more frequent in Enterococcus faecium and Enterococcus faecalis isolates, with no gene cassette array discovered. A combination of gentamicin (MIC 4 µg/mL) with vancomycin (MIC 256 µg/mL) antibiotics against Enterococcus faecalis showed antibacterial activity. In contrast, the combination of ciprofloxacin (1 µg/mL) with Ampicillin (16 µg/mL) antibiotics against Enterococcus faecalis showed a bacteriostatic effect. The ERIC-PCR analysis pointed out that most of the assessed isolates have close genetic similarities.

Int J Environ Res Public Health. 2010 Oct;7(10):3657-703. (PMID: 21139855)
Iran Red Crescent Med J. 2016 Mar 27;18(3):e22260. (PMID: 27247786)
FEMS Immunol Med Microbiol. 2008 Apr;52(3):297-308. (PMID: 18279340)
Annu Rev Genet. 2010;44:141-66. (PMID: 20707672)
Antimicrob Agents Chemother. 2001 Mar;45(3):723-6. (PMID: 11181350)
Int J Environ Res Public Health. 2013 Jan 14;10(1):278-94. (PMID: 23343983)
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7118-22. (PMID: 15107498)
J Water Health. 2013 Dec;11(4):684-91. (PMID: 24334842)
Antimicrob Agents Chemother. 2000 Aug;44(8):2077-80. (PMID: 10898678)
Environ Sci Technol. 2021 Mar 2;55(5):2960-2967. (PMID: 33570908)
Clin Microbiol Infect. 2010 Jun;16(6):541-54. (PMID: 20569265)
Antimicrob Agents Chemother. 1993 Nov;37(11):2427-31. (PMID: 8285628)
Food Microbiol. 2020 Dec;92:103570. (PMID: 32950155)
Vet Microbiol. 2010 Aug 26;144(3-4):493-7. (PMID: 20176451)
FEMS Microbiol Ecol. 2005 Oct 1;54(2):189-96. (PMID: 16332318)
Iran J Microbiol. 2013 Jun;5(2):126-31. (PMID: 23825729)
Curr Microbiol. 2010 Mar;60(3):217-23. (PMID: 19921331)
Int J Antimicrob Agents. 2017 Apr;49(4):507-511. (PMID: 28235571)
Nat Rev Microbiol. 2019 Mar;17(3):141-155. (PMID: 30683887)
Nat Rev Microbiol. 2012 Mar 16;10(4):266-78. (PMID: 22421879)
Appl Environ Microbiol. 2016 Aug 30;82(18):5653-60. (PMID: 27422829)
Res Microbiol. 2012 Feb;163(2):92-100. (PMID: 22127350)
Front Microbiol. 2017 Jun 16;8:1109. (PMID: 28670302)
Infection. 2016 Jun;44(3):273-81. (PMID: 26324294)
Int J Antimicrob Agents. 2015 Jan;45(1):8-18. (PMID: 25465524)
J Antimicrob Chemother. 2006 Mar;57(3):573-6. (PMID: 16431863)
J Clin Microbiol. 1999 Nov;37(11):3497-503. (PMID: 10523541)
Microb Drug Resist. 2012 Oct;18(5):502-9. (PMID: 22546011)
Expert Opin Pharmacother. 2018 Jun;19(9):979-992. (PMID: 29877755)
Diagn Microbiol Infect Dis. 2010 Nov;68(3):315-7. (PMID: 20846812)
Microb Ecol. 2013 Jan;65(1):84-90. (PMID: 22903163)
Infect Genet Evol. 2014 Aug;26:14-9. (PMID: 24815727)
Microb Drug Resist. 2013 Oct;19(5):407-14. (PMID: 23659601)
Cancer Res. 1995 May 15;55(10):2111-5. (PMID: 7743510)
Neurosci Lett. 2012 Jan 6;506(1):107-10. (PMID: 22075224)
Clin Microbiol Rev. 2019 Jan 30;32(2):. (PMID: 30700430)
PLoS One. 2015 Feb 18;10(2):e0117664. (PMID: 25692771)
J Glob Antimicrob Resist. 2019 Sep;18:130-138. (PMID: 31185332)
Ann Lab Med. 2020 Jul;40(4):321-325. (PMID: 32067432)
Antimicrob Agents Chemother. 2014;58(3):1757-62. (PMID: 24395223)
Microbiol Mol Biol Rev. 2012 Dec;76(4):685-706. (PMID: 23204362)
Antimicrob Agents Chemother. 2002 Jan;46(1):188-90. (PMID: 11751132)
Circulation. 2015 Oct 13;132(15):1435-86. (PMID: 26373316)
J Zhejiang Univ Sci B. 2014 Apr;15(4):322-32. (PMID: 24711353)
Jundishapur J Microbiol. 2015 Oct 26;8(10):e27967. (PMID: 26587221)
Int J Environ Res Public Health. 2015 Apr 16;12(4):4231-46. (PMID: 25893999)
Vet Microbiol. 2022 Nov;274:109576. (PMID: 36155350)
Heliyon. 2019 Jun 21;5(6):e01893. (PMID: 31294097)
Expert Rev Anti Infect Ther. 2014 Oct;12(10):1221-36. (PMID: 25199988)
ScientificWorldJournal. 2014;2014:287458. (PMID: 25525617)
Antimicrob Resist Infect Control. 2020 Aug 10;9(1):130. (PMID: 32778149)
Water Res. 2011 Mar;45(6):2342-54. (PMID: 21333318)
Curr Opin Microbiol. 2013 Feb;16(1):10-6. (PMID: 23395351)
J Infect. 2009 Sep;59 Suppl 1:S4-16. (PMID: 19766888)
Protein Sci. 2020 Mar;29(3):654-669. (PMID: 31899563)
Int J Mol Sci. 2014 May 30;15(6):9735-47. (PMID: 24886815)
Iran J Microbiol. 2018 Apr;10(2):104-110. (PMID: 29997750)
Environ Pollut. 2018 Jun;237:406-413. (PMID: 29502003)
Microorganisms. 2020 Jul 20;8(7):. (PMID: 32698489)

SAMRC/UFH /P790 South African Medical Research Council

Keywords: Enterococcus; antibiotic resistance; antimicrobial agents; combination therapy; integron; mobile genetic elements; rate of kill

6Q205EH1VU (Vancomycin)
0 (Anti-Bacterial Agents)
5E8K9I0O4U (Ciprofloxacin)
0 (Gentamicins)

Date Created: 20230211 Date Completed: 20230214 Latest Revision: 20230214

20230214

PMC9917988

10.3390/ijms24032993

36769316